𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Histone deacetylase inhibitors as a potential therapeutic agent for human cancer treatment

✍ Scribed by G. Kouraklis; E. P. Misiakos; S. Theocharis

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
137 KB
Volume
1
Category
Article
ISSN
1776-2596

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibitors of histone deacetylases as po
Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood
✍ Sarah E. Furchert; Claudia Lanvers-Kaminsky; Heribert JuΓΌrgens; Manfred Jung; Ad πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 506 KB

## Abstract The origin of malignant embryonal tumors is incompletely understood and certain risk groups remain difficult to treat. The epigenetic structure of DNA and its lesions play a role in the origin of these neoplasms. Manipulation of the epigenome may offer novel treatment options. The autho

Development of a hammerhead ribozyme aga
Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer
✍ Dorai, Thambi; Olsson, Carl A.; Katz, Aaron E.; Buttyan, Ralph πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

## Background: The bcl-2 oncoprotein suppresses apoptosis and, when overexpressed in prostate cancer cells, makes these cells resistant to a variety of therapeutic agents, including hormonal ablation. therefore, bcl-2 provides a strategic target for the development of gene knockout therapies to tre